BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1974145)

  • 1. Pseudomonas aeruginosa exotoxin A: alterations of biological and biochemical properties resulting from mutation of glutamic acid 553 to aspartic acid.
    Douglas CM; Collier RJ
    Biochemistry; 1990 May; 29(21):5043-9. PubMed ID: 1974145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exotoxin A of Pseudomonas aeruginosa: substitution of glutamic acid 553 with aspartic acid drastically reduces toxicity and enzymatic activity.
    Douglas CM; Collier RJ
    J Bacteriol; 1987 Nov; 169(11):4967-71. PubMed ID: 2889718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active site of Pseudomonas aeruginosa exotoxin A. Glutamic acid 553 is photolabeled by NAD and shows functional homology with glutamic acid 148 of diphtheria toxin.
    Carroll SF; Collier RJ
    J Biol Chem; 1987 Jun; 262(18):8707-11. PubMed ID: 2885323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational integrity of a recombinant toxoid of Pseudomonas aeruginosa exotoxin A containing a deletion of glutamic acid-553.
    Killeen KP; Collier RJ
    Biochim Biophys Acta; 1992 Feb; 1138(2):162-6. PubMed ID: 1347236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa exotoxin A: effects of mutating tyrosine-470 and tyrosine-481 to phenylalanine.
    Lukac M; Collier RJ
    Biochemistry; 1988 Oct; 27(20):7629-32. PubMed ID: 2849995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa cystic fibrosis clinical isolates produce exotoxin A with altered ADP-ribosyltransferase activity and cytotoxicity.
    Gallant CV; Raivio TL; Olson JC; Woods DE; Storey DG
    Microbiology (Reading); 2000 Aug; 146 ( Pt 8)():1891-1899. PubMed ID: 10931893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation into the catalytic role for the tryptophan residues within domain III of Pseudomonas aeruginosa exotoxin A.
    Beattie BK; Prentice GA; Merrill AR
    Biochemistry; 1996 Dec; 35(48):15134-42. PubMed ID: 8952460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diphtheria toxin. Effect of substituting aspartic acid for glutamic acid 148 on ADP-ribosyltransferase activity.
    Tweten RK; Barbieri JT; Collier RJ
    J Biol Chem; 1985 Sep; 260(19):10392-4. PubMed ID: 2863266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active-site mutations of diphtheria toxin: effects of replacing glutamic acid-148 with aspartic acid, glutamine, or serine.
    Wilson BA; Reich KA; Weinstein BR; Collier RJ
    Biochemistry; 1990 Sep; 29(37):8643-51. PubMed ID: 1980208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active site mutations of Pseudomonas aeruginosa exotoxin A. Analysis of the His440 residue.
    Han XY; Galloway DR
    J Biol Chem; 1995 Jan; 270(2):679-84. PubMed ID: 7822295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. His-426 of the Pseudomonas aeruginosa exotoxin A is required for ADP-ribosylation of elongation factor II.
    Wozniak DJ; Hsu LY; Galloway DR
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):8880-4. PubMed ID: 3143111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of eliminating a disulfide bridge within domain II of Pseudomonas aeruginosa exotoxin A.
    Madshus IH; Collier RJ
    Infect Immun; 1989 Jul; 57(7):1873-8. PubMed ID: 2499539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-function analysis of exotoxin A proteins with mutations at histidine 426.
    Wick MJ; Cook JM; Iglewski BH
    Infect Immun; 1992 Mar; 60(3):1128-39. PubMed ID: 1541528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dipeptide insertion in domain I of exotoxin A that impairs receptor binding.
    Chaudry GJ; Wilson RB; Draper RK; Clowes RC
    J Biol Chem; 1989 Sep; 264(25):15151-6. PubMed ID: 2570071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A periplasmic intermediate in the extracellular secretion pathway of Pseudomonas aeruginosa exotoxin A.
    Lu HM; Mizushima S; Lory S
    J Bacteriol; 1993 Nov; 175(22):7463-7. PubMed ID: 7901198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxoid of Pseudomonas aeruginosa exotoxin A generated by deletion of an active-site residue.
    Lukac M; Pier GB; Collier RJ
    Infect Immun; 1988 Dec; 56(12):3095-8. PubMed ID: 2460407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical analysis of CRM 66. A nonfunctional Pseudomonas aeruginosa exotoxin A.
    Galloway DR; Hedstrom RC; McGowan JL; Kessler SP; Wozniak DJ
    J Biol Chem; 1989 Sep; 264(25):14869-73. PubMed ID: 2504713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and immunochemical studies of proteolytic fragments of exotoxin A from Pseudomonas aeruginosa.
    Bourdenet S; Vacheron MJ; Guinand M; Michel G; Arminjon F
    Eur J Biochem; 1990 Sep; 192(2):379-85. PubMed ID: 2170123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of enzymic activity and cytotoxicity of mutant, E553C, Pseudomonas aeruginosa exotoxin A by reaction with iodoacetic acid.
    Lukac M; Collier RJ
    J Biol Chem; 1988 May; 263(13):6146-9. PubMed ID: 3129420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exotoxin A of Pseudomonas aeruginosa: active, cloned toxin is secreted into the periplasmic space of Escherichia coli.
    Douglas CM; Guidi-Rontani C; Collier RJ
    J Bacteriol; 1987 Nov; 169(11):4962-6. PubMed ID: 3117768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.